CareTrust REIT's Dividend Is Well-Backed — the Question Is the Price

CareTrust REIT just announced Q2 2026 results and raised its quarterly dividend to $0.39 a share. The stock trades around $41, giving you a forward yield of about 3.3%. That is not a headline-grabbing number. But the question for an income portfolio is never just how much a security pays — it's whether that payment is durable, whether the cash engine behind it is getting stronger or weaker, and whether the price you're paying lets the yield actually help fund retirement rather than propping up a valuation that already assumes perfection.

Let's look at what's producing the income.

CareTrust doesn't run nursing homes. It buys them — or, more precisely, it buys the real estate and leases it to professional operators under long-term triple-net leases. The operators handle staffing, care, insurance, and maintenance. CareTrust collects rent. The leases carry 2.5% annual inflation escalators, so the rent creeps up even if occupancy and utilization stay flat. About two-thirds of the portfolio is in U.S. skilled nursing and senior housing. A meaningful slice is in U.K. care homes, adding geographic diversification. The company also lends against these assets through its loan portfolio, earning interest income.

That structure matters for the dividend because triple-net leases put operational risk on the operator. CareTrust's exposure is credit risk — will the operator pay the rent — not operating risk — how many residents fill the beds. In Q2, rent collection was 100% of contractual amounts. That is the baseline a dividend-paying REIT needs.

The payout engine

The quarterly dividend is $0.39, annualizing to $1.56 a share. Management says this represents roughly 76% of Normalized FAD (Funds Available for Distribution — the REIT metric that strips out non-cash items and acquisition costs to approximate real cash flow to shareholders). On a Q2 FFO basis, the payout ratio is also about 76%.

That 76% figure is the one to watch. It leaves room. If the income engine holds, 76% coverage means the dividend has cushion against a bad quarter or a slow year. It's not maxed out. It's not stretched to the wire.

The trailing twelve-month payout ratio reported by the market data platform reads 109%, which looks alarming until you understand the mechanics. CareTrust raised the dividend during 2026 — the prior-year quarterly was $0.335. The TTM ratio is backward-looking and captures the older, lower-FFO quarters against the current, higher dividend. It's a timing effect, not a coverage problem. The forward-looking quarterly coverage is what tells you whether the next check clears.

What drove the quarter

Normalized FFO came in at $0.51 per share, up about 19% year-over-year. Total FFO dollars grew roughly 44%, but the per-share number only grew 19% because CareTrust issued equity to fund acquisitions — 14.4 million shares sold under forward contracts in Q2 at a weighted average of $40.23, plus another 2.2 million shares sold post-quarter. That dilution is real and worth noting: the total pie grew faster than your slice.

Revenue jumped 43% to $161.3 million, driven by the massive deployment of capital. CareTrust closed roughly $900 million in new investments during Q2 — a record quarter — at a blended stabilized yield of 8.9%. Year-to-date, about $1.5 billion has been deployed at roughly 8.7%. The company has another $540 million in its investment pipeline.

This is an acquisition-funded growth story. The cash flow is growing because the balance sheet is growing, and the balance sheet is growing because the company is steadily selling equity at prices around $40-$42 to buy assets yielding in the high-single-digits. As long as that spread works — buy yield above your cost of capital — the math compiles.

The balance sheet check

Leverage is conservative. Net debt to annualized EBITDA sits at 1.01x. Total debt is $1.21 billion, with no maturities before 2028. The fixed charge coverage ratio — the test of whether earnings comfortably service debt — is 9.9x. That is a fortress ratio for a REIT. CareTrust also has roughly $605 million available under its $1.2 billion revolving credit facility and about $90 million in cash.

The weighted-average interest rate on debt is 4.39%. New assets are yielding 7.8-8.9% stabilized. The spread is wide enough that funding costs aren't eating the income engine.

The valuation question

Here's where the story gets harder for the new buyer. CareTrust trades at 27 times trailing earnings, 22 times EV/EBITDA, and 2.16 times book value. On a forward P/E basis, it's closer to 36x. Compare that with Spire (SR), another healthcare REIT, which trades at roughly 9 times earnings and 13 times EV/EBITDA with a higher yield near 4.0%. Century Communities (CCS), a different breed of REIT, trades at 15x earnings and under 0.8x book value.

CareTrust is pricing for execution. The market is paying for the idea that this acquisition machine keeps deploying at attractive yields, the pipeline keeps converting, and FFO keeps compounding. The raised guidance supports that — full-year 2026 FFO guidance is $2.03-$2.06 per share, a 16% increase over 2025 results.

But when you're paying 27x trailing earnings for a REIT, the dividend's job as a margin of safety shrinks. You're depending on growth to justify the entry price. If the pipeline dries up, if yields on new deals compress, or if the equity market stops letting CareTrust fund acquisitions by selling shares at $40-plus, the growth story slows and the multiple contracts. That's the valuation risk.

The counterpoint

The bear case isn't about today's cash flow — it's about tomorrow's inputs. Triple-net leases look safe until an operator defaults. The senior housing and skilled nursing sector has been under demographic and regulatory pressure. CareTrust's operators reportedly outperform on quality metrics — star ratings, health inspections, readmission rates — but operator risk is always there. And the heavy reliance on equity issuance to fund growth means that if share prices decline, the company either slows deployment or dilutes existing holders more aggressively. You're already seeing that dilution: per-share growth lagging total FFO growth.

So what does this mean for the income portfolio?

The dividend is safe. 76% coverage, minimal leverage, no near-term maturities, and a business model where the rent checks arrive before anything breaks. If you already own shares at a lower cost basis, this is a hold-for-income name. The cash engine is getting bigger and the payout ratio has room to run.

If you're looking to add, the 3.3% forward yield is fine, not thrilling, and the valuation demands that the acquisition machine keeps working. CareTrust isn't a deep-value income trap — it's a growth REIT that pays a meaningful dividend while it scales. You're not buying it purely for the yield. You're buying it for the idea that FFO keeps compounding, the dividend keeps rising, and total return follows.

The practical entry question is whether you want to buy that story at 27x earnings and 22x EV/EBITDA, or wait for a pullback that lets you buy the same income stream on better terms. If the price drops and the operator track record, leverage profile, and pipeline don't change — which they won't on a typical market swing — the lower price simply means more future income for your dollars. That's the reinvestment logic. The income engine hasn't broken. The question is just the price of admission.